{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:32:47Z","timestamp":1780129967837,"version":"3.54.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100641","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T12:02:24Z","timestamp":1598616144000},"page":"100641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation"],"prefix":"10.1016","volume":"25","author":[{"given":"Melike","family":"Ersoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tiranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zeviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2020.100641_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fgene.2020.00341","article-title":"Novel compound heterozygous variants of ETHE1 causing ethylmalonic encephalopathy in a Chinese patient: A case report","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0010","first-page":"57","article-title":"Neurological and vascular manifestations of ethylmalonic encephalopathy","volume":"11","author":"Tavasoli","year":"2017","journal-title":"Iran J. Child Neurol."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0883073808331359","article-title":"Clinical heterogeneity in ethylmalonic encephalopathy","volume":"24","author":"Pigeon","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/381653","article-title":"Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein","volume":"74","author":"Tiranti","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jmg.2005.036210","article-title":"ETHE1 mutations are specific to ethylmalonic encephalopathy","volume":"43","author":"Tiranti","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.15252\/emmm.201505040","article-title":"Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches","volume":"7","author":"Di Meo","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2006.05.010","article-title":"A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation","volume":"89","author":"Di Rocco","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.braindev.2005.10.005","article-title":"Ethylmalonic encephalopathy\u2014report of two cases","volume":"28","author":"Heberle","year":"2006","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0045","first-page":"57","article-title":"Acute and chronic management in an atypical case of ethylmalonic encephalopathy","volume":"45","author":"Kitzler","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.15252\/emmm.201606345","article-title":"CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome","volume":"9","author":"Luna-S\u00e1nchez","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.2188","article-title":"Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy","volume":"16","author":"Viscomi","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jmg.2008.058271","article-title":"Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy","volume":"45","author":"Mineri","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/BST20180134","article-title":"Towards a therapy for mitochondrial disease: an update","volume":"46","author":"Garone","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011437","article-title":"Altered sulfide (H2S) metabolism in ethylmalonic encephalopathy","volume":"5","author":"Tiranti","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0075","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","article-title":"Why metronidazole is active against both bacteria and parasites","volume":"43","author":"Samuelson","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0080","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.bbadis.2018.09.002","article-title":"CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway","volume":"1864","author":"Kleiner","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100641_bb0085","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/acs.jproteome.6b00100","article-title":"Untargeted metabolomics analysis reveals a link between ETHE1-mediated disruptive redox state and altered metabolic regulation","volume":"15","author":"Sahebekhtiari","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/emmm.201201433","article-title":"Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy","volume":"4","author":"Di Meo","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgmr.2020.100641_bb0095","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/brain\/aww013","article-title":"Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease","volume":"139","author":"Dionisi-Vici","year":"2016","journal-title":"Brain"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:13Z","timestamp":1762001653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920300872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":19,"alternative-id":["S2214426920300872"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100641","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100641"}}